Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials
22 October 2019 - 11:30PM
Business Wire
Newly Allowed
Patent Covers use of the CertainT ® Platform in Cellulosic Fibers and Materials
including Rayon; Company Currently in Discussions with Leading
Manufacturers
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the
“Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA
manufacturing for product authenticity and traceability solutions,
announced today that it has received a Notice of Allowance for its
U.S. Patent Application No. 15/466,016 (US 2017/0292206) entitled
“Methods of Marking Cellulosic Products.” The allowed patent
application, which is expected to be issued as a U.S. patent in the
next few months, extends the Company’s patent protection for its
CertainT platform into cellulosic fibers and materials. The Company
has related international patent applications pending in India, the
European Union, China and Hong Kong.
The allowed claims cover methods of tagging cellulosic fibers or
materials with a nucleic acid (DNA) tag during production and later
authenticating the nucleic acid-tagged cellulosic fibers and/or
materials via PCR-based detection techniques.
Cellulosic fibers and materials are man-made and are derived
from plant-based resources (cellulose). Notable cellulosic fibers
and materials include rayon. The demand for cellulosic fibers and
materials is rapidly expanding, with a market size estimated to
surpass USD 39 billion by 2024, growing at an annual rate of
9%1.
“We are in commercial stage discussions with some of the world’s
largest cellulosic fiber and materials manufacturers for the
implementation of our proven CertainT platform,” said Dr. James
Hayward, president and Chief Executive of Applied DNA. “The newly
allowed patent is a significant milestone for the Company as it
enhances our intellectual property portfolio and provides potential
exclusivity for our CertainT platform in the ever-growing
cellulosic fiber and materials market.”
Dr. Hayward continued: “Since many man-made cellulosic materials
such as rayon (with component fibers known as lyocell, viscose and
modal) are derived from trees, traceability to assure brand claims
for responsible sourcing and sustainable claims is important. The
CertainT solution assists fiber producers in ensuring the
authenticity and traceability of their branded fibers. We have
successfully demonstrated the robust performance of the CertainT
molecular tag in commercial production environments from fiber to
fabric with top-tier rayon manufacturers in both home goods and
apparel.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and isolation of circulating tumor
cells and the development of pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe Applied DNA’s future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA. Actual results could differ
materially from those projected due to its ability to continue as a
going concern, its history of net losses, limited financial
resources, limited market acceptance, uncertainties relating to its
ability to maintain its NASDAQ listing in light of delisting
notices received and its recent hearing, our ability to penetrate
key markets, our ability to successfully enter into commercial
contracts for the implementation of our CertainT® platform, and
various other factors detailed from time to time in Applied DNA’s
SEC reports and filings, including our Annual Report on Form 10-K
filed on December 18, 2018, as amended, our subsequent quarterly
reports on Form 10-Q filed on February 7, 2019, May 9, 2019 and
August 13, 2019, and other reports we file with the SEC, which are
available at www.sec.gov. Applied DNA undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
1
https://www.marketwatch.com/press-release/2019-24-cellulose-fiber-market-to-register-usd-39-bn-revenue-2019-07-22
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191022005579/en/
Investor: Sanjay M. Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.com Program: MeiLin Wan, Vice
President Textile Sales, 631-240-8849, meilin.wan@adnas.com
Web: www.adnas.com Twitter: @apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024